跳至主要内容
临床试验/ITMCTR2000003105
ITMCTR2000003105暂停4 期

Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19)

The First People's Hospital of Jiangxia District, Wuhan0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
暂停
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
7 至 90(—)
性别
All

入选标准

  • 1. Novel coronavirus pneumonia is diagnosed met the fifth edition of the national health and Health Committee;
  • 2. Respiratory rate in calm state >=30 times / min; OR Finger pulse oxygen saturation under rest and non oxygen absorption state <=93%; OR PO2/FiO2)<=300mmHg; OR PO2<60mmHg.

排除标准

  • 1. Aged < 7-year-old;
  • 2. previous arrhythmia;
  • 3. previous chronic respiratory failure caused by other diseases, such as heart failure, thoracic deformity, structural lung disease, etc.;
  • 4. hemodynamic instability;
  • 5. severe immune deficiency or recent use of immunosuppressive agents;
  • 6. allergic patients;
  • 7. estimated survival time less than 3 days;
  • 8. dropout on the halfway as well as lose of follow-up.

研究者

发起方
The First People's Hospital of Jiangxia District, Wuhan

相似试验